Results 1 to 10 of about 29,849 (247)
Current Scientific Advances in Vaccines Against UTIs: Challenges and Prospects [PDF]
MicroorganismsUrinary Tract Infection (UTI), the second most common infectious disease globally, poses a particularly significant threat to adult female populations. Epidemiological data show that Uropathogenic Escherichia coli (UPEC) is responsible for approximately ...
Baoying Wang +8 more
doaj +2 more sources
Биопрепараты: Профилактика, диагностика, лечение, 2018 The present article describes clinical signs of meningococcal disease. It justifies the necessity of its vaccine prevention. The article provides with the historical data on the evolution of inoculants from corpuscular inactivated vaccines to modern ...
M. V. Abramtseva +2 more
doaj +1 more source
Campylobacter polysaccharide capsules: virulence and vaccines [PDF]
Frontiers in Cellular and Infection Microbiology, 2012 Campylobacter jejuni remains a major cause of bacterial diarrhea worldwide and is associated with numerous sequelae, including Guillain Barre Syndrome, inflammatory bowel disease, reactive arthritis, and irritable bowel syndrome. C.
Patricia eGuerry +5 more
doaj +3 more sources
Triptych of the Hermit Saints: pneumococcal polysaccharide vaccines for the elderly. [PDF]
Risk Manag Healthc Policy, 2018 Rijkers GT +3 more
europepmc +3 more sources
Conjugation Mechanism for Pneumococcal Glycoconjugate Vaccines: Classic and Emerging Methods
Bioengineering, 2022 Licensed glycoconjugate vaccines are generally prepared using native or sized polysaccharides coupled to a carrier protein through random linkages along the polysaccharide chain.
Victor Morais, Norma Suarez
doaj +1 more source
Биопрепараты: Профилактика, диагностика, лечение, 2021 Streptococcus pneumoniae infection is the most common cause of high morbidity and mortality among children under 5 years of age, immunocompromised people, and the elderly.
M. V. Savkina +6 more
doaj +1 more source
Vaccines, 2021 Vaccination is a key component of public health policy with demonstrated cost-effective benefits in protecting both human and animal populations. Vaccines can be manufactured under multiple forms including, inactivated (killed), toxoid, live attenuated ...
Majed Ghattas +3 more
doaj +1 more source
Polysaccharide pneumococcal vaccines
BMJ, 2002 Infection with Streptococcus pneumoniae (pneumococcus) is a leading cause of illness in young children and of illness and death in elderly people and people with immune deficiencies and chronic illness. Pneumococcus causes a spectrum of disease: infections of the upper respiratory tract, otitis media, invasive infections such as bacteraemia and ...
Tom, Jefferson, Vittorio, Demicheli
openaire +5 more sources
Promising pharmaceutical development of vaccines for the prevention of meningococcal infection
Журнал микробиологии, эпидемиологии и иммунобиологии, 2023 Meningococcal infection (MI) refers to anthroponoses; is an acute infectious disease with an aerosol transmission mechanism, characterized by various forms of the infectious process: from local (nasopharyngitis) and asymptomatic infections to generalized
Maria V. Savkina +3 more
doaj +1 more source